ArticleFrontiers in pharmacology2016

Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin.

Veronika Wetzl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.